Complete regression of #hepatoblastoma, the most common pediatric #liverCancer, in a 3-year-old treated with a novel #immunotherapy. A.Heckzey, D. Steffin et al @bcmhouston.bsky.social @nejm.org www.bcm.edu/news/care-st...